Voya Financial Advisors Inc. Acquires 1,091 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Voya Financial Advisors Inc. grew its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 20.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 6,300 shares of the financial services provider’s stock after buying an additional 1,091 shares during the period. Voya Financial Advisors Inc.’s holdings in iShares Nasdaq Biotechnology ETF were worth $961,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of IBB. Filbrandt Wealth Management LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $26,000. Bainco International Investors purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $27,000. Key Financial Inc purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $30,000. Alpha DNA Investment Management LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $32,000. Finally, Cowa LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 79.80% of the company’s stock.

Shares of iShares Nasdaq Biotechnology ETF stock opened at $148.85 on Thursday. iShares Nasdaq Biotechnology ETF has a 12-month low of $109.36 and a 12-month high of $174.04. The company’s 50-day moving average price is $154.90 and its 200-day moving average price is $152.85.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: How is the LIBOR rate calculated?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.